Tag: Bureau of Competition

Displaying 21 - 40 of 863 results.

Pages

The Federal Trade Commission testified today before the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law on the role of antitrust enforcement in the debate over network neutrality.
In an Initial Decision announced today, Chief Administrative Law Judge D. Michael Chappell upheld a Federal Trade Commission complaint against 1-800 Contacts, ruling that the agency has proved that the nation’s largest online retailer of contact lenses unlawfully orchestrated a web of...
Federal Trade Commission staff has submitted comments to Frank W. Berry, Commissioner of the Georgia Department of Community Health, supporting a Certificate of Need (CON) application filed by Lee County Medical Center.
The Federal Trade Commission’s Economic Liberty Task Force has announced the agenda for its second roundtable in Washington, DC on November 7, 2017, to examine empirical evidence on the effects of occupational licensing.
The Federal Trade Commission has announced an agenda for its upcoming workshop on competition issues related to prescription drug markets. The workshop, titled “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics,” will take place on November 8, 2017 at the FTC’s...
The Federal Trade Commission is seeking public comment on an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic.
The Federal Trade Commission will hold a workshop on November 8, 2017 entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr. Scott Gottlieb will give the keynote addresses.
Following a public comment period, the Federal Trade Commission has approved a final order in which the National Association of Animal Breeders agreed to refrain from adopting rules that unreasonably stifle competition among its members.
In order to reduce the burden associated with submitting detailed information for every document withheld on a claim of privilege, the Bureau has established an optional two-step privilege log process. Rather than submitting a complete privilege log for all withheld documents and...
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
The Hatch-Waxman Act, passed by Congress more than 30 years ago, provides a regulatory and judicial framework to expedite generic entry into U.S. prescription drug markets. For many drugs, the Act has succeeded in lowering patent-related barriers to generic drug entry, thereby...
In testimony presented to a U.S. House Judiciary Subcommittee, Acting Federal Trade Commission Chairman Maureen K. Ohlhausen described the FTC’s extensive work on the potential competitive effects of excessive occupational licensing through research, education, advocacy, and enforcement.
The Federal Trade Commission and Department of Justice today announced the release of antitrust guidance for businesses taking part in relief efforts and those involved in rebuilding communities affected by Hurricanes Harvey and Irma.
The Federal Trade Commission’s Economic Liberty Task Force announced today that it will hold its second roundtable in Washington, DC on Nov.
On November 7, 2017, the Federal Trade Commission’s Economic Liberty Task Force hosted a roundtable to examine empirical evidence on the effects of occupational licensure.
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced today that she has selected Ian R. Conner, a partner in the Antitrust & Competition group at the law firm of Kirkland & Ellis LLP, to be an Acting Deputy Director of the FTC’s Bureau of Competition, effective Sept. 18,...

Pages